Insights

Innovative Product Portfolio Iconovo's proprietary dry powder inhalers and inhouse formulation capabilities offer significant opportunities to partner with pharmaceutical companies seeking to develop or commercialize inhalation-based therapies, especially in areas like biologics and new drug delivery platforms.

Strategic Collaborations Recent partnership with Lonza Group to develop intranasal biologic formulations highlights Iconovo's potential as a collaborator for companies exploring advanced drug delivery methods, opening avenues for joint product development and shared market entry strategies.

Recognition & Awards Being awarded the Best Inhalation Therapy Company 2024 by EU Business News enhances credibility and visibility among potential clients and investors, positioning Iconovo as a leading innovator in inhalation technology and increasing sales opportunities.

Market Expansion Efforts Recent grants for market efforts in South Korea and ongoing studies on inhalable oxytocin present opportunities to engage with healthcare providers and pharmaceutical companies in emerging markets seeking novel inhalation treatments.

Growing R&D Focus Iconovo’s active development of new inhalation therapies, including improved nasal inhalers and biologic formulations, indicates an expanding product pipeline ideal for OEM partnerships, licensing agreements, or distribution collaborations to accelerate market access.

Iconovo AB Tech Stack

Iconovo AB uses 8 technology products and services including Open Graph, Shopify, Twemoji, and more. Explore Iconovo AB's tech stack below.

Open Graph

Content Management System

Shopify

E-commerce

Twemoji

Font Scripts

Font Awesome

Font Scripts

Priority Hints

Performance

Microsoft Azure

Platform As A Service

HSTS

Security

ZURB Foundation

UI Frameworks

Iconovo AB Email Formats	Example	Percentage
First.Last@iconovo.se	John.Doe@iconovo.se	84%
Last.First@iconovo.se	Doe.John@iconovo.se	6%
Last@iconovo.se	Doe@iconovo.se	7%
First.Middle@iconovo.se	John.Michael@iconovo.se	3%

Iconovo AB Email Formats

Example

Percentage

First.Last@iconovo.se

John.Doe@iconovo.se

84%

Last.First@iconovo.se

Doe.John@iconovo.se

Last@iconovo.se

Doe@iconovo.se

First.Middle@iconovo.se

John.Michael@iconovo.se

Frequently Asked Questions

Where is Iconovo AB's headquarters located?

Iconovo AB's main headquarters is located at 3b Ideongatan Lund, Skåne 223 70 Sweden. The company has employees across 1 continents, including Europe.

What is Iconovo AB's official website and social media links?

Iconovo AB's official website is iconovo.se and has social profiles on LinkedIn Crunchbase.

What is Iconovo AB's NAICS code?

Iconovo AB's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Iconovo AB have currently?

As of June 2026, Iconovo AB has approximately 22 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: A. M.Cto: L. A.Chief Financial Officer: H. S.. Explore Iconovo AB's employee directory with LeadIQ.

What industry does Iconovo AB belong to?

Iconovo AB operates in the Pharmaceutical Manufacturing industry.

What technology does Iconovo AB use?

Iconovo AB's tech stack includes Open GraphShopifyTwemojiFont AwesomePriority HintsMicrosoft AzureHSTSZURB Foundation.

What is Iconovo AB's email format?

Iconovo AB's email format typically follows the pattern of First.Last@iconovo.se. Find more Iconovo AB email formats with LeadIQ.

How much funding has Iconovo AB raised to date?

As of June 2026, Iconovo AB has raised $51K in funding. The last funding round occurred on Mar 31, 2023 for $51K.

When was Iconovo AB founded?

Iconovo AB was founded in 2013.

Iconovo AB

Q: What is Iconovo AB's official website and social media links?

Iconovo AB's official website is iconovo.se. Iconovo AB has social profiles on LinkedIn.

Q: How many employees does Iconovo AB have currently?

Iconovo AB has approximately 22 employees.

Q: What technology does Iconovo AB use?

Iconovo AB's tech stack includes DoubleClick Floodlight, Google Tag Manager, Shopify, Twemoji, Open Graph.

Q: What is Iconovo AB's NAICS code?

Iconovo AB's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingSkåne, Sweden11-50 Employees

Iconovo AB operates in pharmaceutical manufacturing with a focus on inhaled medicinal products developed in collaboration with international pharmaceutical companies. The company leverages patented dry powder inhalers and manages both device development and formulation in-house, aiming to reduce development risk and shorten the time to market for new therapies and generic medicines. Based in Lund, in the Skåne region of Sweden, Iconovo serves global pharmaceutical customers seeking reliable inhalation delivery solutions. It emphasizes end-to-end control of the technology to support efficient development timelines for inhaled drugs. In January 2025, Iconovo announced a partnership with Lonza to develop spray-dried formulations of an intranasal biologic.

Insights

Similar companies to Iconovo AB

WuXi AppTec

Alcami Corporation

Iconovo AB Tech Stack

Media & News

Iconovo AB partnered with Lonza Group on Jan 13th '25.

Iconovo AB receives award Best Inhalation Therapy Company 2024.

Iconovo AB recognized as Best Inhalation Therapy Company 2024.

Iconovo AB launches Q1-2024 report.

Iconovo AB is developing inhalable oxytocin treatment based on ICOone.

Iconovo AB received financing of $65K in grant on Mar 5th '24.

Iconovo AB launches improved versions of nasal ICOone inhalers.

Iconovo AB's Email Address Formats